Equities research analysts forecast that Nu Skin Enterprises, Inc. (NYSE:NUS) will report earnings of $0.89 per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for Nu Skin Enterprises’ earnings, with the highest EPS estimate coming in at $0.91 and the lowest estimate coming in at $0.85. Nu Skin Enterprises posted earnings of $0.77 per share during the same quarter last year, which suggests a positive year over year growth rate of 15.6%. The company is expected to report its next quarterly earnings results on Wednesday, August 1st.
According to Zacks, analysts expect that Nu Skin Enterprises will report full-year earnings of $3.55 per share for the current fiscal year, with EPS estimates ranging from $3.48 to $3.58. For the next financial year, analysts expect that the business will report earnings of $3.91 per share, with EPS estimates ranging from $3.66 to $4.27. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side analysts that that provide coverage for Nu Skin Enterprises.
Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Thursday, April 26th. The company reported $0.79 EPS for the quarter, topping the consensus estimate of $0.70 by $0.09. The firm had revenue of $616.00 million during the quarter, compared to analysts’ expectations of $564.46 million. Nu Skin Enterprises had a return on equity of 25.36% and a net margin of 5.74%. Nu Skin Enterprises’s quarterly revenue was up 23.4% compared to the same quarter last year. During the same period last year, the business earned $0.51 earnings per share.
NUS has been the subject of several recent analyst reports. Jefferies Financial Group initiated coverage on Nu Skin Enterprises in a research note on Thursday. They set a “buy” rating and a $98.00 price objective for the company. Deutsche Bank increased their price objective on Nu Skin Enterprises from $75.00 to $77.00 and gave the stock a “buy” rating in a research note on Friday, February 16th. Pivotal Research reiterated a “buy” rating and set a $90.00 price objective on shares of Nu Skin Enterprises in a research note on Friday, February 16th. ValuEngine lowered Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 6th. Finally, Citigroup increased their price objective on Nu Skin Enterprises from $81.00 to $82.00 and gave the stock a “buy” rating in a research note on Monday, April 30th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and five have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $77.00.
Nu Skin Enterprises stock traded up $1.55 during mid-day trading on Friday, hitting $83.53. 530,599 shares of the company were exchanged, compared to its average volume of 514,187. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.14 and a quick ratio of 0.75. Nu Skin Enterprises has a 1-year low of $53.50 and a 1-year high of $84.00. The firm has a market capitalization of $4.51 billion, a P/E ratio of 25.89, a P/E/G ratio of 2.74 and a beta of 1.34.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 13th. Stockholders of record on Friday, May 25th were paid a $0.365 dividend. The ex-dividend date was Thursday, May 24th. This represents a $1.46 dividend on an annualized basis and a dividend yield of 1.75%. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 45.20%.
In other news, General Counsel D Matthew Dorny sold 3,250 shares of the firm’s stock in a transaction on Monday, April 2nd. The stock was sold at an average price of $72.22, for a total value of $234,715.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Chairman Steven Lund sold 81,000 shares of the firm’s stock in a transaction on Wednesday, April 4th. The shares were sold at an average price of $75.00, for a total value of $6,075,000.00. Following the completion of the sale, the chairman now owns 4,769 shares of the company’s stock, valued at $357,675. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 109,750 shares of company stock valued at $8,259,910. 3.00% of the stock is currently owned by corporate insiders.
Large investors have recently made changes to their positions in the company. Allianz Asset Management GmbH bought a new position in Nu Skin Enterprises in the first quarter valued at about $293,000. Principal Financial Group Inc. boosted its holdings in Nu Skin Enterprises by 2.3% in the first quarter. Principal Financial Group Inc. now owns 217,221 shares of the company’s stock valued at $16,011,000 after acquiring an additional 4,781 shares during the last quarter. WINTON GROUP Ltd bought a new position in Nu Skin Enterprises in the first quarter valued at about $740,000. CIBC World Markets Inc. bought a new position in Nu Skin Enterprises in the first quarter valued at about $1,228,000. Finally, Xact Kapitalforvaltning AB boosted its holdings in Nu Skin Enterprises by 58.6% in the first quarter. Xact Kapitalforvaltning AB now owns 8,116 shares of the company’s stock valued at $598,000 after acquiring an additional 3,000 shares during the last quarter. Institutional investors own 76.89% of the company’s stock.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.